Kapil Kumar Bhawarlal Jain
About Kapil Kumar Bhawarlal Jain
Data last updated:
Kapil Kumar Bhawarlal Jain has 19 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Verogen Healthcare Private Limited and Hoechst Pharmaceuticals Llp. Formerly with 4 companies, such as Jenesis Pharma Trading Llp and Plasmagen Biosciences Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹1.17 Cr; the largest is Hoechst Pharmaceuticals Llp at ₹89 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hoechst Pharmaceuticals Llp ABA-9921 | Designated Partner | 12 May 2022 | 2022 | ₹89 Lakh (FY 2023) | Active |
| Verogen Healthcare Private Limited U24100TN2014PTC094601 | Director | 16 Jan 2014 | 2014 | ₹28.2 Lakh (FY 2022) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Jenesis Pharma Trading Llp AAR-6031 | Designated Partner | 14 Jan 2020 | 2020 | – | Active |
 Plasmagen Biosciences Private Limited U51909KA2010PTC055077 | Director | 07 Sep 2010 | 2010 | ₹162 Cr (FY 2025) | Active |
 Avinya Lifesciences Private Limited U74999KA2018PTC110215 | Director | 17 Feb 2018 | 2018 | ₹1.2 Lakh (FY 2025) | Active |
 Trigenesis Lifesciences Private Limited U24231KA2004PTC034182 | Director | 18 Jun 2007 | 2004 | ₹1.44 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kapil Kumar Bhawarlal Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kapil Kumar Bhawarlal Jain
Kapil Kumar Bhawarlal Jain has 19 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Verogen Healthcare Private Limited and Hoechst Pharmaceuticals Llp. Formerly with 4 companies, such as Jenesis Pharma Trading Llp and Plasmagen Biosciences Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹1.17 Cr; the largest is Hoechst Pharmaceuticals Llp at ₹89 Lakh (FY 2023).
Kapil Kumar Bhawarlal Jain is associated with 2 companies as Director and Designated Partner, including Hoechst Pharmaceuticals Llp (₹89 Lakh), Verogen Healthcare Private Limited (₹28.2 Lakh).
Kapil Kumar Bhawarlal Jain has expertise in Healthcare, General Business.
Kapil Kumar Bhawarlal Jain has 19 years in corporate governance.
By reported revenue, the largest current company of Kapil Kumar Bhawarlal Jain is Hoechst Pharmaceuticals Llp, with revenue of ₹89 Lakh (FY 2023).
The 2 current companies of Kapil Kumar Bhawarlal Jain that report revenue have a combined latest revenue of ₹1.17 Cr.
Kapil Kumar Bhawarlal Jain currently holds positions at 2 companies: Hoechst Pharmaceuticals Llp (₹89 Lakh), Verogen Healthcare Private Limited (₹28.2 Lakh).